Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-05T02:53:54.242Z Has data issue: false hasContentIssue false
  • English
  • Français

Pterin metabolism in depression: an extension of the amine hypothesis and possible marker of response to ECT

Published online by Cambridge University Press:  09 July 2009

David N. Anderson ,
Mohammed T. Abou-Saleh ,
James Collins ,
Kevin Hughes ,
Richard J. Cattell ,
Christopher G. B. Hamon ,
John A. Blair  and
Michael E. Dewey
David N. Anderson*
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
Mohammed T. Abou-Saleh
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
James Collins
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
Kevin Hughes
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
Richard J. Cattell
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
Christopher G. B. Hamon
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
John A. Blair
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
Michael E. Dewey
Affiliation:
Department of Psychiatry, Fazakerley Hospital, Liverpool; University Department of Psychiatry, Royal Liverpool Teaching Hospital, Liverpool; Pharmaceutical Sciences Institute, Aston University, Birmingham
*
1 Address for correspondence: Dr D. N. Anderson, Department of Psychiatry, Fazakerley Hospital, Longmoor Lane, Liverpool L9 7AL.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Urinary excretion of neopterins and biopterins was measured in 23 patients with severe depression before and after receiving electroconvulsive therapy (ECT) and 26 healthy control subjects. Patients with psychotic depression and those responding to ECT had neopterin:biopterin (N:B) ratio significantly higher than controls before commencing ECT and positive therapeutic response was associated with reduction of N:B ratio towards control values. As a raised N:B ratio implies failure to convert neopterin to biopterin it is possible that reduced availability of tetrahydrobiopterin, the essential cofactor for the formation of noradrenaline, serotonin and dopamine, may exert rate limiting control over the synthesis of monoamines implicated in the pathogenesis of depressive disorders. The N:B ratio may be a marker for certain depressive subtypes and response to ECT.

Type
Original Articles
Information
Psychological Medicine , Volume 22 , Issue 4 , November 1992 , pp. 863 - 869
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorder (3rd edn). American Psychiatric Association: Washington, DC.Google Scholar
Aziz, A. A., Leeming, R. J. & Blair, J. A. (1983). Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry 46, 410–413.CrossRefGoogle ScholarPubMed
Barford, P. A., Blair, J. A., Eggar, C., Hamon, C. G. B., Morar, C. & Whitburn, S. B. (1984). Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry 47, 746–738.CrossRefGoogle ScholarPubMed
Blair, J. A., Morar, C., Hamon, C. G. B., Barford, P. A., Pheasant, A. E.Whitburn, S. B., Leeming, R. J., Reynolds, G. P. & Coppen, A. (1984). Tetrahydrobiopterin metabolism in depression. Lancet ii, 163.CrossRefGoogle Scholar
Brandon, S., Cowley, P., McDonald, C., Neville, P., Palmer, R. & Wellstood-Eason, S. (1984). Electroconvulsive therapy: results in depressive illness from the Leicestershire trial. British Medical Journal 288, 22–25.CrossRefGoogle ScholarPubMed
Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A. A., Haskett, R. F., James, N., Fronfol, Z., Lohr, N., Steiner, M., de Vigne, J. P. & Young, E. (1981). A specific laboratory test for the diagnosis of melancholia. Archives of General Psychiatry 38, 15–22.CrossRefGoogle ScholarPubMed
Checkley, S. (1985). Biological markers in depression. In Recent Advances in Clinical Psychiatry 5 (ed. Granville-Grossman, K.), pp. 200–224. Churchill Livingstone: New York.Google Scholar
Clinical Research Centre, Division of Psychiatry (1984). The Northwick Park ECT trial. Predictors of response to real and simulated ECT. British Journal of Psychiatry 144, 227–237.CrossRefGoogle Scholar
Coppen, A., Swade, C., Jones, S. A., Armstrong, R. A., Blair, J. A. & Leeming, R. J. (1989). Depression and tetrahydrobiopterin: the folate connection. Journal of Affective Disorders 16, 103–107.CrossRefGoogle ScholarPubMed
Curtius, H.-Ch., Muldner, H. & Niederwieser, A. (1982). Tetrahydrobiopterin: efficacy in endogenous depression and Parkinson's disease. Neural Transmission 55, 301–308.CrossRefGoogle Scholar
Dhondt, J.-L. (1984). Tetrahydrobiopterin deficiencies: preliminary analysis from an international survey. Journal of Pediatrics 104, 501–508.CrossRefGoogle ScholarPubMed
Duch, D. S., Woolf, J. H., Nichol, C. A., Davidson, J. R. & Garbutt, J. C. (1984). Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Research 11, 83–89.CrossRefGoogle ScholarPubMed
Hamilton, M. (1969). Standardised assessment of depressive symptoms. Psychiatry, Neurology and Neurosurgery 72, 201–205.Google ScholarPubMed
Hamon, C. G. B. & Blair, J. A. (1987). Tetrahydrobiopterin metabolism in disease. In Unconjugated Pterins in Neurobiology: Basic and Clinical Aspects (ed. Lovenberg, W. and Levine, R. A.), pp. 201–213. Taylor & Francis: London.Google Scholar
Hosoda, S. & Glick, D. (1966). Studies in histochemistry. LXXIX. Properties of tryptophan hydroxylase from neoplastic murine mast cells. Journal of Biological Chemistry 241, 192–196.CrossRefGoogle ScholarPubMed
Kellner, C. H., Rakita, R. M., Rubinow, D. A., Gold, P. W., Ballenger, J. C. & Post, R. M. (1983). Tetrahydrobioplerin levels in cerebrospinal fluid of affectively ill patients. Lancet ii, 55–56.CrossRefGoogle Scholar
Leeming, R. J. (1979). Metabolism of biopterin and its derivatives in man and the rat. Ph.D. thesis, University of Aston.Google Scholar
Leeming, R. J. & Blair, J. A. (1980). The effects of pathological and normal physiological processes on biopterin derivative levels in man. Clinica Chimica Acta 108, 103–111.CrossRefGoogle ScholarPubMed
Leeming, R. J., Blair, J. A., Melikian, V. & O'Gorman, D. J. (1976). Biopterin derivatives in human body fluids and tissues. Journal of Clinical Pathology 29, 444–451.CrossRefGoogle Scholar
Leeming, R. J., Blair, J. A. & Melikian, V. (1979). Biopterin derivatives in senile dementia. Lancet i, 215.CrossRefGoogle Scholar
Leeming, R. J., Blair, J. A. & Walters, J. (1982). Serum dihydrobiopterin levels in patients on tricyclic antidepressants. Psychological Medicine 12, 191–192.CrossRefGoogle ScholarPubMed
Leeming, R. J., Barford, P. A., Blair, J. A. & Smith, I. (1984). Blood spots on Guthrie cards can be used for inherited tetrahydrobiopterin deficiency screening in hyperphenylalanaemic infants. Archives of Diseases in Childhood 59, 58–61.CrossRefGoogle Scholar
Levine, R. A., Williams, A. C., Robinson, D. S., Calne, D. B. & Lovenberg, W. (1979). Analysis of hydroxylase cofactor activity in the cerebrospinal fluid of patients with Parkinson's disease. Advances in Neurology 24 (ed. Poirier, L. J., Sourkes, T. L. and Bedard, P. J.), pp. 303–307. Raven Press: New York.Google Scholar
Levine, R. A. & Lovenberg, W. (1984). CSF tetrahydrobiopterin levels in patients with affective disorders. Lancet ii, 283.CrossRefGoogle Scholar
Levitt, M., Spector, S., Sjoerdsman, P. & Udenfried, S. (1965). Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. Journal of Pharmacology and Experimental Therapeutics 148, 1–8.Google ScholarPubMed
Lovenberg, W., Levine, R. A., Robinson, D. S., Ebert, M., Williams, A. C. & Calne, D. B. (1979). Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science 204, 624–626.CrossRefGoogle ScholarPubMed
Mandell, A. J., Bullard, W. P., Yellin, J. B. & Russo, P. V. (1980). The influence of D-amphetamine on rat brain striatal reduced biopterin concentration. Journal of Pharmacology and Experimental Therapeutics 213, 569–574.Google ScholarPubMed
Montgomery, S. A. & Åsberg, M. (1979). A new depression rating scale designed to be sensitive to change. British Journal of Psychiatry 134, 382–389.CrossRefGoogle ScholarPubMed
Morar, C., Whitburn, S. B., Blair, J. A., Leeming, R. J. & Wilcock, G. K. (1983). Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry 46, 582–590.CrossRefGoogle ScholarPubMed
Nagatsu, T., Yamaguchi, T., Kato, T., Sugimoto, T., Matsuura, S., Akino, M., Nagatsu, I., Iizuka, R. & Narabayashi, H. (1981). Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay. Clinica Chimica Acta 109, 305–311.CrossRefGoogle ScholarPubMed
Nagatsu, T., Yamaguchi, T., Rahman, M. K., Trocewicz, J., Oka, K., Yoko, H., Hirata, Y., Nagatsu, I., Narabayashi, H., Kondo, T. & Iizuka, R. (1984). Catecholamine-related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases. Advances in Neurology 40 (ed. Hassler, R. G. and Christ, J. F.), pp. 467–473. Raven Press: New York.Google Scholar
Nichol, C. A., Smith, G. K. & Duch, S. D. (1985). Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annual Reviews in Biochemistry 54, 729–764.CrossRefGoogle ScholarPubMed
Paykel, E. S. (1989). Treatment of depression. The relevance of research for clinical practice. British Journal of Psychiatry 155, 754–763.CrossRefGoogle ScholarPubMed
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: a review of the supporting evidence. American Journal of Psychiatry 122, 509–522.CrossRefGoogle ScholarPubMed
Scott, A. I. F. (1989). Which depressed patients will respond to electroconvulsive therapy? The search for biological predictors of recovery. British Journal of Psychiatry 154, 8–17.CrossRefGoogle ScholarPubMed
Smith, I., Howells, D. W. & Hyland, K. (1986). Pteridines and monoamines: relevance to neurological damage. Postgraduate Medical Journal 62, 113–123.CrossRefGoogle ScholarPubMed
Spitzer, R. L., Endicott, J. & Robins, E. (1978). Research Diagnostic Criteria. Rationale and reliability. Archives of General Psychiatry 35, 773–782.CrossRefGoogle ScholarPubMed
Switchenko, A. & Brown, G. (1985). The enzymatic conversion of dihydroneopterin triphosphate to 6-pyruvoyltetrahydrobiopterin, an intermediate in the biosynthesis of other pterins in Drosophila Melanogaster. Journal of Biological Chemistry 260, 2945–2951.CrossRefGoogle Scholar
van Kammen, D. P., Levine, R. A. & Sternberg, D. (1978). Preliminary evaluation of hydroxylase cofactor in human spinal fluid: potential biochemical and clinical relevance. Psychopharmacology Bulletin 4, 51–52.Google Scholar
van Praag, H. H. (1982). Depression. Lancet ii, 1259–1264.CrossRefGoogle Scholar
Werner, E. R., Bichler, A., Daxenbichler, G., Fuchs, D., Fuith, L. C., Hausen, A., Hetzel, H., Reibnegger, G. & Wachter, H. (1987). Determination of neopterin in serum and urine. Clinical Chemistry 33, 62–66.CrossRefGoogle ScholarPubMed
Williams, A. C., Levine, R. A., Chase, T. N., Lovenberg, W. & Calne, D. B. (1980). CSF hydroxylase cofactor levels in some neurological diseases. Journal of Neurology. Neurosurgery & Psychiatry 43, 735–738CrossRefGoogle Scholar
Young, J. H., Kelly, B. & Clayton, B. E. (1982). Reduced levels of biopterin and dihydropteridine reductase in Alzheimer type dementia. Journal of Clinical and Experimental Gerontology 4, 389–402.Google Scholar